NasdaqGS - Nasdaq Real Time Price USD

Acadia Healthcare Company, Inc. (ACHC)

74.38 +1.00 (+1.36%)
As of 11:51 AM EDT. Market Open.
Loading Chart for ACHC
DELL
  • Previous Close 73.38
  • Open 73.75
  • Bid 74.29 x 100
  • Ask 74.49 x 100
  • Day's Range 73.21 - 74.47
  • 52 Week Range 66.49 - 87.77
  • Volume 278,804
  • Avg. Volume 592,229
  • Market Cap (intraday) 6.875B
  • Beta (5Y Monthly) 1.31
  • PE Ratio (TTM) --
  • EPS (TTM) -0.24
  • Earnings Date May 1, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 95.58

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

www.acadiahealthcare.com

17,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ACHC

Performance Overview: ACHC

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ACHC
4.35%
S&P 500
6.93%

1-Year Return

ACHC
0.81%
S&P 500
25.27%

3-Year Return

ACHC
19.60%
S&P 500
22.01%

5-Year Return

ACHC
131.79%
S&P 500
74.30%

Compare To: ACHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACHC

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    6.78B

  • Enterprise Value

    8.18B

  • Trailing P/E

    --

  • Forward P/E

    20.75

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.28

  • Price/Book (mrq)

    2.44

  • Enterprise Value/Revenue

    2.79

  • Enterprise Value/EBITDA

    43.27

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.74%

  • Return on Assets (ttm)

    6.12%

  • Return on Equity (ttm)

    -0.54%

  • Revenue (ttm)

    2.93B

  • Net Income Avi to Common (ttm)

    -21.67M

  • Diluted EPS (ttm)

    -0.24

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    100.07M

  • Total Debt/Equity (mrq)

    52.32%

  • Levered Free Cash Flow (ttm)

    411.35M

Research Analysis: ACHC

Analyst Price Targets

70.00
95.58 Average
74.38 Current
105.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: ACHC

Fair Value

74.38 Current
 

Dividend Score

0 Low
ACHC
Sector Avg.
100 High
 

Hiring Score

0 Low
ACHC
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
ACHC
Sector Avg.
100 High
 

Research Reports: ACHC

  • ACHC: Lowering target price to $74.00

    ACADIA HEALTHCARE CO INC has an Investment Rating of HOLD; a target price of $74.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • ACHC: Lowering target price to $75.00

    ACADIA HEALTHCARE CO INC has an Investment Rating of HOLD; a target price of $75.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • ACHC: What does Argus have to say about ACHC?

    ACADIA HEALTHCARE CO INC has an Investment Rating of HOLD; a target price of $80.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • ACHC: Lowering target price to $80.00

    ACADIA HEALTHCARE CO INC has an Investment Rating of HOLD; a target price of $80.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     

People Also Watch